Device type · NHB
Polymer, Ear, Nose And Throat, Synthetic, Absorbable
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NHB
Ear, Nose & Throat
Device class
Class II
FDA decisions since 2015
9
510(k), De Novo and PMA
Adverse event reports
20
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Polymer, Ear, Nose And Throat, Synthetic, Absorbable
- Product code
- NHB
- Device class
- Class II
- Review panel
- Ear, Nose & Throat
- Regulation
- 21 CFR 874.3620
- Specialty
- Otolaryngology (ENT)
- FDA record
- Classification database entry for NHB
Latest FDA decisions
The 8 newest of 9 since 2015.
- SeptAlign (SPLN001)510(k)
K260620 · Decided Jul 30, 2026 · 155 days after receipt
Device type: Polymer, Ear, Nose And Throat, Synthetic, Absorbable (NHB) · Otolaryngology (ENT)
- SeptAlign510(k)
K251790 · Decided Jan 16, 2026 · 219 days after receipt
Device type: Polymer, Ear, Nose And Throat, Synthetic, Absorbable (NHB) · Otolaryngology (ENT)
- SeptAlign510(k)
K233569 · Decided Mar 22, 2024 · 137 days after receipt
Device type: Polymer, Ear, Nose And Throat, Synthetic, Absorbable (NHB) · Otolaryngology (ENT)
6 more FDA decisions with a free account
Reports received
20
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
9
45% of reports
Injury reports
11
55% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 1 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 3 | 1 | 0 | 0 |
| Mar 24 | 1 | 1 | 0 | 0 |
| Apr 24 | 2 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 3 | 0 | 0 |
| Jul 24 | 2 | 0 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 2 | 1 | 0 | 0 |
| Dec 24 | 2 | 0 | 0 | 0 |
| Jan 25 | 3 | 2 | 0 | 0 |
| Feb 25 | 0 | 1 | 0 | 0 |
| Mar 25 | 0 | 3 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 2 | 0 | 0 | 0 |
| Jun 25 | 0 | 2 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 | 0 |
| Aug 25 | 2 | 0 | 0 | 0 |
| Sep 25 | 1 | 1 | 0 | 0 |
| Oct 25 | 0 | 1 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 0 | 2 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 | 0 |
| Apr 26 | 1 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 3 | 0 | 0 | 0 |
| Aug 26 | 0 | 3 | 0 | 0 |
| Sep 26 | 0 | 5 | 0 | 0 |
| Oct 26 | 2 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
2 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem8
- Migration5
- Insufficient Device Problem Information3
2 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Insufficient Information6
- Hyporesponsive to stimuli4
- Unspecified Tissue Injury4
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Otopore Cylinder Standard outer ear dressings, Catalog Numbers 5400-010-000 and 5400-010-000ITLOpen, Classified
Z-1469-2025 · Started Feb 25, 2025 · Posted by FDA Mar 28, 2025
Reason given: There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.
Cause as FDA categorized it: Under Investigation by firm
- Nasopore Standard 4cm fragmentable nasal dressing, Catalog Numbers 5400-010-004 and 5400-010-004ITLOpen, Classified
Z-1470-2025 · Started Feb 25, 2025 · Posted by FDA Mar 28, 2025
Reason given: There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.
Cause as FDA categorized it: Under Investigation by firm
- Nasopore Standard 8cm fragmentable nasal dressing, Catalog Numbers 5400-010-008 and 5400-010-008ITLOpen, Classified
Z-1471-2025 · Started Feb 25, 2025 · Posted by FDA Mar 28, 2025
Reason given: There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.
Cause as FDA categorized it: Under Investigation by firm
12 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.